Rett Syndrome Latest Advances

Retraction Note: Neurotrophic effects of Cerebrolysin in the Mecp2308/Y transgenic model of Rett syndrome.

Journal: Acta neuropathologica

Published: March 24, 2026

Exon skipping to treat Rett syndrome.

Journal: Nature reviews. Drug discovery

Published: March 24, 2026

mPFC pyramidal neuron synchrony during social competition to form social rankings is disrupted in male Mecp2 knockout mice.

Journal: bioRxiv : the preprint server for biology

Published: March 18, 2026

A KCNC1 variant linked to Rett syndrome disrupts ER to Golgi trafficking of Kv3.1 channel.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 12, 2026

MECP2-Associated Rett Syndrome Without Developmental Regression-A Case Series.

Journal: Journal of child neurology

Published: March 12, 2026

Features of premorbid status in patients with Rett syndrome

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: March 05, 2026

Modulating alternative splicing of MECP2 is a potential therapeutic strategy for Rett syndrome.

Journal: Science translational medicine

Published: March 04, 2026

Sociodemographic Profiles and Age-Related Differences in Comorbidities, Sleep, and Quality of Life of Turkish Children with Rett Syndrome and their Families.

Journal: Neuropediatrics

Published: February 23, 2026

MECP2 MBD-ID Module: A Unified DNA/RNA Binding Interface Disrupted in Rett Syndrome.

Journal: bioRxiv : the preprint server for biology

Published: February 23, 2026

CDKL5 modulates the plasticity of excitatory synapses via liquid-liquid phase separation.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: February 18, 2026

Rett syndrome

Journal: MMW Fortschritte der Medizin

Published: February 16, 2026

Endocannabinoid Enhancement via MAGL Inhibition in CDKL5 Deficiency: Selective Cellular Benefits and Domain-Specific Functional Effects in Adult Cdkl5 KO Mice.

Journal: International journal of molecular sciences

Published: February 11, 2026

Rett Syndrome Latest Advances

Find the Latest Research About Rett Syndrome

Retraction Note: Neurotrophic effects of Cerebrolysin in the Mecp2308/Y transgenic model of Rett syndrome.

Retraction Note: Neurotrophic effects of Cerebrolysin in the Mecp2308/Y transgenic model of Rett syndrome.

Exon skipping to treat Rett syndrome.

Exon skipping to treat Rett syndrome.

mPFC pyramidal neuron synchrony during social competition to form social rankings is disrupted in male Mecp2 knockout mice.

mPFC pyramidal neuron synchrony during social competition to form social rankings is disrupted in male Mecp2 knockout mice.

A KCNC1 variant linked to Rett syndrome disrupts ER to Golgi trafficking of Kv3.1 channel.

A KCNC1 variant linked to Rett syndrome disrupts ER to Golgi trafficking of Kv3.1 channel.

MECP2-Associated Rett Syndrome Without Developmental Regression-A Case Series.

MECP2-Associated Rett Syndrome Without Developmental Regression-A Case Series.

Features of premorbid status in patients with Rett syndrome

Features of premorbid status in patients with Rett syndrome

Modulating alternative splicing of MECP2 is a potential therapeutic strategy for Rett syndrome.

Modulating alternative splicing of MECP2 is a potential therapeutic strategy for Rett syndrome.

Sociodemographic Profiles and Age-Related Differences in Comorbidities, Sleep, and Quality of Life of Turkish Children with Rett Syndrome and their Families.

Sociodemographic Profiles and Age-Related Differences in Comorbidities, Sleep, and Quality of Life of Turkish Children with Rett Syndrome and their Families.

MECP2 MBD-ID Module: A Unified DNA/RNA Binding Interface Disrupted in Rett Syndrome.

MECP2 MBD-ID Module: A Unified DNA/RNA Binding Interface Disrupted in Rett Syndrome.

CDKL5 modulates the plasticity of excitatory synapses via liquid-liquid phase separation.

CDKL5 modulates the plasticity of excitatory synapses via liquid-liquid phase separation.

Rett syndrome

Rett syndrome

Endocannabinoid Enhancement via MAGL Inhibition in CDKL5 Deficiency: Selective Cellular Benefits and Domain-Specific Functional Effects in Adult Cdkl5 KO Mice.

Endocannabinoid Enhancement via MAGL Inhibition in CDKL5 Deficiency: Selective Cellular Benefits and Domain-Specific Functional Effects in Adult Cdkl5 KO Mice.